Search

Your search keyword '"Steinbach, Angela"' showing total 19 results
Start Over Author "Steinbach, Angela"
19 results on '"Steinbach, Angela"'

1. VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe

Author

Salmanton-García, Jon, Wipfler, Pauline, Valle-Simón, Paula, Merakou, Christina, Kopsidas, Ioannis, Bethe, Ullrich, Steinbach, Angela, Spivak, Orly, Součková, Lenka, Mendonça, Maria Amélia, Koniordou, Markela, Hellemans, Margot, Frías-Iniesta, Jesus, Davis, Ruth Joanna, Barta, Imre, Azzini, Anna Maria, Askling, Helena H., Argyropoulos, Christos D., Álvarez-Barco, Elena, Akova, Murat, Bonten, Marc M.J., Cohen-Kandli, Miriam, Cox, Rebecca Jane, Flisiak, Robert, Husa, Petr, Jancoriene, Ligita, Koscalova, Alena, Launay, Odile, Lundgren, Jens, Mallon, Patrick, Marques, Laura, Nauclér, Pontus, Ochando, Jordi, Pana, Zoi-Dorothea, Tacconelli, Evelina, Tóth, Krisztina, Trelle, Sven, van Damme, Pierre, Zaoutis, Theoklis E., Zeitlinger, Markus, Albus, Kerstin, Stewart, Fiona A., Hofstraat, Sanne H.I., Bruijning-Verhagen, Patricia, and Cornely, Oliver A.

Published
2023
Full Text
View/download PDF

2. Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients (DOPPIO): Protocol for a Prospective Multicenter Study

Author

Mellinghoff, Sibylle, primary, von Gersdorff, Gero, additional, Bruns, Caroline, additional, Albus, Kerstin, additional, Dimitriou, Vassiliki, additional, Steinbach, Angela, additional, Schaller, Mathias, additional, Vehreschild, Jörg Janne, additional, Cornely, Oliver A, additional, and Liss, Blasius Janusch, additional

Published
2023
Full Text
View/download PDF

3. Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients (DOPPIO): Protocol for a Prospective Multicenter Study (Preprint)

Author

Mellinghoff, Sibylle, primary, von Gersdorff, Gero, additional, Bruns, Caroline, additional, Albus, Kerstin, additional, Dimitriou, Vassiliki, additional, Steinbach, Angela, additional, Schaller, Mathias, additional, Vehreschild, Jörg Janne, additional, Cornely, Oliver A, additional, and Liss, Blasius Janusch, additional

Published
2023
Full Text
View/download PDF

4. VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment

Author

Salmanton-García, Jon, primary, Stewart, Fiona A., additional, Heringer, Sarah, additional, Koniordou, Markela, additional, Álvarez-Barco, Elena, additional, Argyropoulos, Christos D., additional, Themistocleous, Sophia C., additional, Valle-Simón, Paula, additional, Spivak, Orly, additional, Součková, Lenka, additional, Merakou, Christina, additional, Amélia Mendonça, Maria, additional, Joanna Davis, Ruth, additional, Maria Azzini, Anna, additional, Askling, Helena H., additional, Vene, Sirkka, additional, Van Damme, Pierre, additional, Steinbach, Angela, additional, Shiamakkides, George, additional, Seidel, Danila, additional, Olesen, Ole F., additional, Noula, Evgenia, additional, Macken, Alan, additional, Luís, Catarina, additional, Leckler, Janina, additional, Launay, Odile, additional, Isitt, Catherine, additional, Hellemans, Margot, additional, Frías-Iniesta, Jesús, additional, Di Marzo, Romina, additional, Carcas, Antonio J., additional, Boustras, George, additional, Borobia, Alberto M., additional, Barta, Imre, additional, Albus, Kerstin, additional, Akova, Murat, additional, Ochando, Jordi, additional, Cohen-Kandli, Miriam, additional, Jane Cox, Rebecca, additional, Husa, Petr, additional, Jancoriene, Ligita, additional, Mallon, Patrick, additional, Marques, Laura, additional, Mellinghoff, Sibylle C., additional, Nauclér, Pontus, additional, Tacconelli, Evelina, additional, Tóth, Krisztina, additional, Zaoutis, Theoklis E., additional, Zeitlinger, Markus, additional, Cornely, Oliver A., additional, and Pana, Zoi-Dorothea, additional

Published
2022
Full Text
View/download PDF

13. Mucormycosis treated with posaconazole: review of 96 case reports

Author

Vehreschild, Joerg J., primary, Birtel, Andrea, additional, Vehreschild, Maria J. G. T., additional, Liss, Blasius, additional, Farowski, Fedja, additional, Kochanek, Matthias, additional, Sieniawski, Michal, additional, Steinbach, Angela, additional, Wahlers, Kerstin, additional, Fätkenheuer, Gerd, additional, and Cornely, Oliver A., additional

Published
2012
Full Text
View/download PDF

18. Mucormycosis treated with posaconazole: review of 96 case reports.

Author

Vehreschild, Joerg J., Birtel, Andrea, Vehreschild, Maria J. G. T., Liss, Blasius, Farowski, Fedja, Kochanek, Matthias, Sieniawski, Michal, Steinbach, Angela, Wahlers, Kerstin, Fätkenheuer, Gerd, and Cornely, Oliver A.

Abstract

Mucormycosis is an emerging invasive fungal infection, primarily affecting immunocompromised patients. The disease is difficult to diagnose and mortality reaches 40% even if treated adequately. Depending on site of infection and risk factors, surgical debridement in combination with systemically active antifungal drugs are the mainstay treatment strategies. Lipid-based amphotericin B is the treatment of choice for first-line therapy while posaconazole may be a promising alternative. We performed a PubMed search on reports of patients with mucormycosis treated with posaconazole. From 2003 to 2011, 96 cases have been published. Diagnosis was based on histology alone in 2 (2.1%) and microbiological evidence in 67 (69.8%), while no data on the diagnostic approach was reported in 27 (28.1%) patients. The most frequent pathogens were Rhizopus spp. (31.2%), followed by Mucor spp. (14.6%). The site of infection was predominantly rhino-orbital (38.5%, of which 43% also had central nervous system [CNS] involvement), followed by disseminated disease (22.1%). A complete response was achieved in 62 (64.6%), partial response in 7 (7.3%) patients, and stable disease in 1 (1%). Overall mortality was 24% (lacking data for three patients). In published case reports on posaconazole treatment for mucormycosis, the drug was frequently and successfully used in combination or as second line therapy. [ABSTRACT FROM AUTHOR]

Published
2013
Full Text
View/download PDF

19. Diagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients

Author

Vehreschild, Jörg J, Rüping, Maria JGT, Steinbach, Angela, and Cornely, Oliver A

Abstract

Importance of the field:Invasive fungal diseases (IFD) are severe complications in patients receiving immunosuppression after solid organ or allogeneic stem cell transplantation. Extensive study has been conducted on therapeutic strategies for IFD in neutropenic patients, mostly those with hematological malignancy. There is an ongoing discussion on whether these studies may be applied to transplant patients as well.Areas covered in this review:We have reviewed relevant literature on transplantation and clinical mycology of the last 20 years and selected articles relevant for today's treatment decisions. This article reports on the epidemiology of IFD in transplant recipients and current antifungal drugs in the context of tansplantation medicine. For invasive aspergillosis and invasive candidiasis, we give a detailed report of current clinical evidence.What the reader will gain:This review is intended as a quick-start for clinicians and other care providers new to transplant care and as an update for experienced transplant physicians. In a field in which evidence is scarce and conflicting, we provide evidence-based strategies for diagnosing and treating the most relevant IFD in transplant recipients.Take home message:Physicians treating transplant patients should maintain a high level of awareness towards IFD. They should know the local epidemiology of IFD to make the optimal decision between current diagnostic and therapeutic strategies. Prophylaxis or early treatment should be considered given the high mortality of IFD.

Published
2010
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results